Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-01-02 @ 3:45 AM
Study NCT ID:
NCT05545969
Status:
WITHDRAWN
Last Update Posted:
2024-06-26
First Post:
2022-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma
Sponsor:
Melanoma Institute Australia
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MIA2022/442
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |